Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
Alfredomaria Lurati,1 Antonella Laria,1 Daniela Mazzocchi,1 Katia Angela Re,1 Maria Grazia Marrazza,1 Paola Maria Faggioli,2 Antonino Mazzone2 1Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, Italy; 2Internal Medicine Unit, Legnano Hospital, Milan, ItalyCorrespondence: Alfredomaria Lurat...
Saved in:
Main Authors: | Lurati A, Laria A, Mazzocchi D, Re KA, Marrazza MG, Faggioli PM, Mazzone A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/25b05d17f5b84971bc43f6a35f853242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
by: Findeisen KE, et al.
Published: (2021) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
by: Mysler E, et al.
Published: (2021) -
The onset of rheumatoid arthritis following trauma
by: Brawer AE, et al.
Published: (2016) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
by: Almalag H, et al.
Published: (2020) -
Management of rheumatoid arthritis during pregnancy: challenges and solutions
by: Krause ML, et al.
Published: (2016)